Matches in Wikidata for { <http://www.wikidata.org/entity/Q86587405> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q86587405 description "2013 թվականի ապրիլի 10-ին հրատարակված գիտական հոդված" @default.
- Q86587405 description "article scientifique publié en 2013" @default.
- Q86587405 description "artículu científicu espublizáu n'abril de 2013" @default.
- Q86587405 description "im April 2013 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86587405 description "scientific article published on 10 April 2013" @default.
- Q86587405 description "wetenschappelijk artikel" @default.
- Q86587405 description "наукова стаття, опублікована у квітні 2013" @default.
- Q86587405 name "[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]" @default.
- Q86587405 name "[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]" @default.
- Q86587405 type Item @default.
- Q86587405 label "[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]" @default.
- Q86587405 label "[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]" @default.
- Q86587405 prefLabel "[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]" @default.
- Q86587405 prefLabel "[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]" @default.
- Q86587405 P1433 Q86587405-0B930E64-DB97-418E-82DE-87D6554F9886 @default.
- Q86587405 P1476 Q86587405-9AA92388-00B5-44AE-B33E-09287885ED7A @default.
- Q86587405 P2093 Q86587405-DED44CA0-6DAD-4D8D-835D-854F3BF36564 @default.
- Q86587405 P304 Q86587405-64084FD2-7B2D-41B0-A23D-9517D576B387 @default.
- Q86587405 P31 Q86587405-E99F15D8-C7D9-4C21-A0D1-FCE214DCA182 @default.
- Q86587405 P356 Q86587405-2123C428-B92C-4BD7-961B-B9946A0C9BDF @default.
- Q86587405 P433 Q86587405-9B52B19E-DBA9-4E11-A701-03951C2A7482 @default.
- Q86587405 P478 Q86587405-C9FBDE0B-2852-4E27-A5E7-B519B71B54D6 @default.
- Q86587405 P50 Q86587405-8E25E868-06F6-44F0-A6E9-465B75486767 @default.
- Q86587405 P577 Q86587405-5AC1034F-88C7-4FA8-8B0B-11DC1B06DF6A @default.
- Q86587405 P698 Q86587405-D151BD84-DB6F-4085-97D5-474959FBAB0A @default.
- Q86587405 P356 J.NRL.2013.01.008 @default.
- Q86587405 P698 23582372 @default.
- Q86587405 P1433 Q26841855 @default.
- Q86587405 P1476 "[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]" @default.
- Q86587405 P2093 "B Hernández" @default.
- Q86587405 P304 "1-10" @default.
- Q86587405 P31 Q13442814 @default.
- Q86587405 P356 "10.1016/J.NRL.2013.01.008" @default.
- Q86587405 P433 "1" @default.
- Q86587405 P478 "29" @default.
- Q86587405 P50 Q43114694 @default.
- Q86587405 P577 "2013-04-10T00:00:00Z" @default.
- Q86587405 P698 "23582372" @default.